Related Experiment Video

Updated: Jun 7, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.5K

PCRX-201, a novel IL-1Ra gene therapy treatment approach for low back pain resulting from intervertebral disc

Joseph W Snuggs1,2, Rebecca K Senter3, Joshua P Whitt3

  • 1Division of Clinical Medicine, The University of Sheffield, Sheffield, UK.

Gene Therapy
|November 21, 2024
PubMed

Insights

Low back pain is linked to intervertebral disc degeneration. A new gene therapy, PCRX-201, increases interleukin-1 receptor antagonist (IL-1Ra) to inhibit degeneration pathways, offering a potential treatment.

Area of Science:

  • Regenerative Medicine
  • Gene Therapy
  • Orthopedics

Background:

  • Low back pain is a leading global disability, primarily caused by intervertebral disc (IVD) degeneration.
  • Current treatments for IVD degeneration do not address the underlying pathological mechanisms.
  • Interleukin-1 (IL-1) signaling drives the catabolic degeneration of the IVD.

Purpose of the Study:

  • To assess the efficacy of PCRX-201, a novel gene therapy vector, in treating intervertebral disc degeneration.
  • To determine if PCRX-201 can transduce human nucleus pulposus cells and increase Interleukin-1 Receptor Antagonist (IL-1Ra) production.
  • To evaluate the impact of PCRX-201-induced IL-1Ra on catabolic pathways in degenerate IVD cells and tissues.

Main Methods:

  • Gene therapy vector (PCRX-201) administration to human nucleus pulposus cells and tissue.
  • Measurement of IL-1Ra production and release post-transduction.
  • Analysis of downstream catabolic markers, including IL-1β, IL-6, MMP3, ADAMTS4, and VEGF.
  • Assessment of aggrecan expression.

Main Results:

  • PCRX-201 successfully transduced degenerate human nucleus pulposus cells and tissue, significantly increasing IL-1Ra production.
  • Transduction with PCRX-201 led to a decrease in pro-inflammatory and catabolic factors (IL-1β, IL-6, MMP3, ADAMTS4, VEGF).
  • PCRX-201 treatment resulted in increased aggrecan expression and inhibition of IL-1-driven catabolic signaling.

Conclusions:

  • PCRX-201 demonstrates the potential to inhibit IL-1-driven intervertebral disc degeneration by increasing IL-1Ra.
  • The gene therapy vector effectively reduces key catabolic markers associated with disc degeneration.
  • PCRX-201 shows promise as a novel therapeutic strategy for intervertebral disc degeneration, warranting further investigation.

More Related Videos

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.05:46

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.

Published on: February 14, 2021

3.6K
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

234

Related Concept Videos

Herniated Intervertebral Disc l: Introduction01:29

Herniated Intervertebral Disc l: Introduction

Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...